Published yesterday in Public Library of Science (PLoS), a new study done in mice with human immune systems show that mice given Pre-exposure prophylaxis (PrEP) did not contract HIV vaginally.
Though the study has not been tried in humans, it offers some hope for what may be possible to prevent women from contracting HIV vaginally--especially since the use of PrEP may be done without the consent or knowledge of a (consentual) sex partner. If this proves effective in women, the political hurdles to getting ARVs in the hands of women is going to be a huge battle.
I love the Public Library of Science for providing free access to peer-reviewed studies for people, and providing great summaries for thos of us not scientifically trained or inlcined. Here's what they said:
Editors' Summary
Background.
"Since the first cases
of acquired immunodeficiency syndrome (AIDS) in 1981, the AIDS epidemic
has spread rapidly. About 33 million people are now infected with the
human immunodeficiency virus (HIV), the cause of AIDS. More than half
of newly acquired infections now occur in women, mostly through
unprotected vaginal sex with an infected male partner. Women are
biologically more susceptible than men to HIV infection during vaginal
intercourse and often cannot persuade their partner to use a condom.
Consequently, alternative strategies that prevent intravaginal
transmission of HIV (infection through the vagina) are urgently needed,
particularly strategies that women can use without their partner's
agreement. A vaccine would be ideal but it could be many years before
an effective HIV vaccine is available so researchers are investigating
other preventative strategies such as the use of microbicides—compounds
that protect against HIV when applied inside the vagina—and
pre-exposure treatment (prophylaxis) with antiretroviral drugs.
Why Was This Study Done?
Before
any new strategy to prevent intravaginal HIV transmission is tried by
women, it has to be tested in animals. Currently, this can only be done
in macaques, an expensive option. In this study, the researchers have
investigated whether “humanized BLT” mice could be used instead. When
HIV enters the human body during vaginal intercourse, it sticks to
dendritic cells (a type of immune system cell) in the vaginal lining.
These cells carry the virus to the body's lymphoid tissues (collections
of immune cells), where it infects and kills CD4+ T cells (another type of immune cell). Dendritic cells and CD4+
T cells have molecules on their surface that HIV recognizes. Mice are
not normally susceptible to infection with HIV because their immune
system cells lack these molecules. Humanized BLT mice have a nearly
human immune system—BLT stands for bone marrow, liver, thymus. They are
produced by implanting pieces of human fetal liver and thymus (the
organ where T cells learn to recognize foreign invaders) under the
kidney capsule of immunodeficient mice (animals born without an immune
system) and then transplanting human hematopoietic stem cells (the
source of the major immune system cells) into the mice.
What Did the Researchers Do and Find?
When the researchers examined the female reproductive tract of humanized BLT mice for human immune system cells, they found CD4+
T cells, dendritic cells and macrophages, all of which are involved in
HIV infection. Furthermore, half of the blood cells of the BLT mice
were human. Most of the BLT mice, the researchers report, were
susceptible to intravaginal HIV infection as shown, for example, by a
rapid loss of human CD4+ T cells from their blood. However,
BLT mice pretreated with antiretroviral drugs (a mixture of
emtricitabine and tenofovir disoproxil fumarate) were resistant to
intravaginal HIV infection. As in human HIV infections, CD4+
T cells were also depleted in several other organs of the BLT mice
after intravaginal HIV infection. Again, this depletion was prevented
by antiretroviral pre-exposure prophylaxis. Finally, human CD4+ T cells also disappeared from the gut-associated lymphoid tissue (an important site for HIV replication and CD4+ T cell depletion during human HIV disease) of the BLT mice after infection with HIV.
read more »
What Do These Findings Mean?
These
findings show that humanized BLT mice are susceptible to intravaginal
infection with HIV and that many aspects of HIV infection in these mice
closely mimic infection in people. In addition, by showing that
pre-exposure prophylaxis with antiretroviral drugs prevents HIV
infection, these results suggest that humanized BLT mice could be used
to test new strategies designed to prevent intravaginal infection. As
with all animal models, any approach that works in humanized BLT mice
will still have to be tested in people. Nevertheless, these findings
provide preclinical evidence that pre-exposure prophylaxis with
antiretroviral drugs may be an effective way to prevent intravaginal
transmission of HIV and, therefore, provide valuable support for
clinical trials of this approach."